Tumor necrosis factor-α stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP

Diabetes

Volumn 51, Issue 10, 2002, Pages 2929-2935

  Zhang, Hui H ^a   Halbleib, Melanie ^a   Ahmad, Faiyaz ^b   Manganiello, Vincent C ^b   Greenberg, Andrew S ^a  

^a TUFTS UNIVERSITY   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PERILIPIN; PHOSPHOPROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; ELECTROPHORESIS; ENZYME ACTIVATION; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; LIPOLYSIS; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT;

EID: 0036789186     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.10.2929     Document Type: Article

References (43)

1. Boden G: Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46:3-10, 1997
2. Feingold KR, Doerrler W, Dinarello CA, Fiers W, Grunfeld C: Stimulation of lipolysis in cultured fat cells by tumor necrosisfactor, interleukin-1, and the interferons is blocked by inhibition of prostaglandin synthesis. Endocrinology 130:10-16, 1992
3. Green A, Dobias SB, Walters DJA, Brasier AR: Tumor necrosis factor increases the rate of lipolysis in primary cultures of adipocytes without altering levels of hormone-sensitive lipase. Endocrinology 134:2581-2588, 1994
4. Hauner H, Petruschke T, Russ M, Rohrig K, Eckel J: Effects of tumor necrosis factor alpha (TNFα) on glucose transport and lipid metabolism of newly differentiated human fat cells in cell culture. Diabetologia 38:764-771, 1995
5. Kawakami M, Murase T, Ogawa H, Ishibashi S, Mori N, Takaku F, Shibata S: Human recombinant TNF suppresses lipoprotein lipase activity and stimulates lipolysis in 3T3-L1 cells. J Biochem 101:331-338, 1987
6. Souza SC, Yamamoto MT, Franciosa MD, Lien P, Greenberg AS: BRL 49653 blocks the lipolytic actions of tumor necrosis factor-α: a potential new insulin-sensitizing mechanism for the thiazolidinediones. Diabetes 47:691-695, 1998
7. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM: Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest 95:2409-2415, 1995
8. Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 259:87-91, 1993
9. Kern P, Ranganathan S, Wood L, Ranganathan G: Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 280:E745-E751, 2001
10. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB: The expression of tumor necrosis factor in human adipose tissue: regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 95:2111-2119, 1995
11. Orban Z, Remaley A, Sampson M, Trajanoski Z, Chrousos G: The differential effect of food intake and β-adrenergic stimulation on adipose-derived hormones and cytokines in man. J Clin Endocrinol Metab 84:2126-2133, 1999
12. Evans R, Illic V, Williamson D: Acute administration of tumor necrosis factor-alpha or interleukin-1 does not mimic the hypoketonaemia associated with sepsis and inflammatory stress in the rat. Clin Sci 82:205-209, 1992
13. Starnes HF, Warren R, Jeevanandam M, Gabriliove J, Larchian W, Oettgen H, Brennan M: Tumor necrosis factor and the acute metabolic response to tissue injury in man. J Clin Invest 82:1321-1325, 1988
14. Van Der Poll T, Romijn J, Endert E, Borm J, Buller H, Sauerwein H: Tumor necrosis factor mimics the metabolic response to acute infection in healthy humans. Am J Physiol 261:E457-E465, 1991
15. Uysal K, Wiesbrock S, Marino M, Hotamisligil GS: Protection from obesity-linked insulin resistance in mice lacking TNF-α function. Nature 389:610-614, 1997
16. Souza S, Palmer H, Lien P, Paulson K: TNF-α increases lipolysis through activation of ERK and JNK1 MAP kinase pathways in 3T3-L1 adipocytes (Abstract). Diabetes 47(Suppl. 1):A338, 1998
17. Wallach D, Varfolomeev E, Malini N, Goltsev Y, Kovalenko A, Boldin M: Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunology 17:331-367, 1999
18. Engelman JA, Berg AH, Lewis RY, Lisanti MP, Scherer PE: Tumor necrosis factor-α-mediated insulin resistance, but not dedifferentiation, is abrogated by MEK1/2 inhibitors in 3T3-L1 adipocytes. Mol Endocrinol 14:1557-1569, 2000
19. Greenberg A, Shen W, Muliro K, Patel S, Souza S, Roth R, Kraemer F: Stimulation of lipolysis and hormone-sensitive lipase via the extracellular signal related kinase pathway. J Biol Chem 276:454456-445461, 2001
20. Brasaemle D, Rubin B, Harten I, Gruia-Gray J, Kimmel A, Londos C: Perilipin A increases triacylglycerol storage by decreasing the rate of triacylglycerol hydrolysis. J Biol Chem 275:38486-38493, 2000
21. Greenberg A, Egan J, Wek S, Garty NEJ, Blanchette-Mackie E, Londos C: Perilipin, a major hormonally regulated adipocyte-specific phosphoprotein associated with the periphery of the lipid storage droplets. J Biol Chem 266:11341-11346, 1991
22. db/db mice. Nat Genet 26:474-479, 2000
23. Souza S, Moitoso de Vargas L, Yamamato M, Line P, Franciosa M, Moss L, Greenberg A: Overexpression of perilipin A and B blocks the ability of tumor necrosis factor to increase adipocyte lipolysis in 3T3-L1 adipocytes. J Biol Chem 273:24665-24669, 1998
24. Souza S, Muliro K, Liscum L, Lien P, Yamamoto Y, Schaffer J, Dallal G, Wang X, Kraemer F, Obin M, Greenberg A: Modulation of hormone-sensitive lipase and protein kinase-A-mediated lipolysis by perilipin A in an adenoviral reconstituted system. J Biol Chem 277:8267-8272, 2001
25. Tansey J, Sztalryd C, Gruia-Gray J, Roush D, Zeo J, Gavrilova O, Reitman M, Deng, C-X, Ki C, Kimmel A, Londos C: Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity. Proc Natl Acad Sci U S A 98:6494-6499, 2001
26. Clifford G, Londos C, Kraemer F, Vernon R, Yeaman S: Translocation of hormone-sensitive lipase and perilipin upon lipolytic stimulation of rat adipocytes. J Biol Chem 275:5011-5015, 2000
27. Londos C, Brasaemle D, Schultz C, Segrest J, Kimmel A: Perilipins ADRP, and other proteins that associate with intracellular neutral lipid droplets in animal cells. Semin Cell Dev Biol 10:51-58, 1999
28. Landstrom R, Mie J, Karlsson M, Manganiello V, Degereman E: Downregulation of cyclic nucleotide phosphodiesterase 3B in 3T3-L1 adipocytes induced by tumor necrosis factor α and cAMP. Biochem J 346:337-343, 2000
29. Rodbell M: Metabolism of isolated fat cells-effect of hormones on glucose metabolism and lipolysis. J Biol Chem 239:375-380, 1964
30. Della Rocca G, van Biesen T, Daaka Y, Luttrell D, Luttrell L, Lefkowitz R: Ras-dependent mitogen-activated protein kinase activation by G protein coupled receptors: convergence of Gi- and Gq-mediated pathways on calcium, calmodulin, Pyk2, and Src kinase. J Biol Chem 272:19125-19132, 1997
31. i protein concentrations. J Biol Chem 274: 6770-6775, 1999
32. Cobb M, Goldsmith E: How MAP kinases are regulated? J Biol Chem 270:14843-14846, 1995
33. Davis R: The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 268:14553-14556, 1993
34. Alessi D, Cuenda A, Cohen P, Dudley D, Saltiel A: PD 98059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 70:27489-27494, 1995
35. Favata M, Horiuchi K, Manos E, Daulerio A, Stradley D, Feeser W, Van Dyk D, Pitts W, Earl R, Hobbs F, Copeland R, Magolda R, Scherle P, Trzaskos J: Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 273:18623-18632, 1998
36. Blenis J: Signal transduction via the MAP kinases: proceed at your own RSK. Proc Natl Acad Sci U S A 90:5889-5892, 1993
37. Hu E, Kim JB, Sarraf P, Spiegelman B: Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARγ. Science 274:2100-2103, 1996
38. Blanchette-Mackie EJ, Dwyer NK, Barber T, Coxey RA, Takeda T, Rondonine CM, Theodoraldas JL, Greenberg AS, Londos C: Perilipin is located on the surface layer of the intracellular lipid droplets in adipocytes. J Lipid Res 36:1211-1226, 1995
39. Egan JJ, Greenberg AS, Chang M-K, Londos C: Control of endogenous phosphorylation of the major cAMP-dependent β-adrenergic stimulation. J Biol Chem 265:18769-18775, 1990
40. Greenberg A, Egan J, Wek S, Moos J MC, Londos C, Kimmel A: Isolation of cDNAs for perilipins A and B: sequence and expression of lipid droplet-associated proteins of adipocytes. Proc Natl Acad Sci U S A 90: 12035-12039, 1993
41. Anthonsen M, Ronnstrand L, Wernstedt C, Degerman E, Holm C: Identification of novel phosphorylation sites in hormone-sensitive lipase that are phosphorylated in response to isoproterenol and govern activation properties in vivo. J Biol Chem 273:215-221, 1998
42. Fredrikson G, Stralfors P, Nilsson NO, Belfrage P: Hormone-sensitive lipase of rat adipose tissue: purification and some properties. J Biol Chem 356:6311-6320, 1981
43. Shen W, Patel S, Natu V, Kraemer F: Mutational analysis of structural features of rat hormone-sensitive lipase. Biochemistry 37:8973-8979, 1998